MDT vs ZNTL · P/E 21, rev $36.36B vs $257.7M cap
Medtronic PLC (MDT) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the MDT and ZNTL stock pages for the full models.
Not investment advice.